A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer Meeting Abstract
| Authors: | Pai, S.; Adkins, D.; Wirth, L.; Chung, C.; Gibson, M.; Sukari, A.; Worden, F.; Colevas, D.; Saba, N.; Burtness, B.; Rodriguez, C.; Bauman, J.; Glisson, B.; Dunn, L.; Suri, A.; Haydock, M.; Quayle, S.; Cemerski, S.; Leader, M.; Brown, J.; Pienta, K.; Simcox, M. |
| Abstract Title: | A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A216 |
| Language: | English |
| ACCESSION: | WOS:000616665300343 |
| DOI: | 10.1136/jitc-2020-SITC2020.0354 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 354 -- Source: Wos |
